Össur hf: Management changes

Report this content

Announcement no. 74/2019
9 December 2019

New R&D leadership

Kim de Roy, EVP of Research & Development (R&D), is leaving Össur after leading the R&D function for the last 2 years.

As of today, Dr. Kristleifur Kristjansson has been appointed EVP of R&D and will become a member of Össur's Executive Management. Dr. Kristjansson joined Össur in 2012, for the first 5 years as Medical Officer and in the last 2 years as Medical Officer and VP of Clinical Affairs. Dr. Kristjansson holds a Medical Doctor degree from the University of Iceland and is a Board-Certified Pediatrician from the Medical College of Georgia, in addition to completing a clinical and molecular genetics fellowship from the Baylor College of Medicine in Houston, Texas and has been a certified Pediatrician and Clinical Geneticist in Iceland from 1993. Dr. Kristjansson’s previous positions include co-founder and VP of Clinical Affairs and Collaborations at deCODE genetics ehf. 1995 to 2012 and co-founder and CEO of Pediatric Services in Iceland 1995 to 2014. Dr. Kristjansson has acted as a consulting Pediatrician and Clinical Geneticist for the University Hospital, Landspitalinn Reykjavik Iceland, from 1998 to the present, and he is the Founder and Chairman of the Board of Skraeda ehf.

Jon Sigurdsson, President & CEO, comments:

"Dr. Kristleifur Kristjansson brings with him a wealth of experience and expertise and he has been a valuable member of our team for the last 7 years. For the last 2 years Kim de Roy has been an instrumental force in driving our innovation strategy. On behalf of all Össur employees I thank him for his contribution to Össur."

Further information

David Hreidarsson, Investor Relations, dhreidarsson@ossur.com, +354 515 1380

Össur press releases by e-mail

If you wish to receive Össur press releases by e-mail please register at http://www.ossur.com/investors

About Össur

Össur (NASDAQ OMX: OSSR) is a global leader in non-invasive orthopaedics that help people live a life without limitations. Its business is focused on improving people’s mobility through the delivery of innovative technologies within the fields of Prosthetics and Bracing & Supports. A recognized “Technology Pioneer,” Össur invests significantly in research and product development—its award-winning designs ensuring a consistently strong position in the market. Successful patient and clinical outcomes are further empowered via Össur’s educational programs and business solutions. Headquartered in Iceland, Össur has major operations in the Americas, Europe and Asia, with additional distributors worldwide. www.ossur.com